Article Details

iBio Inc. (NYSE: IBIO) Jumps 6% after Appointment of Evert Schimmelpennink to Its Board

Retrieved on: 2021-06-12 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

iBio Inc. (NYSE: IBIO) Jumps 6% after Appointment of Evert Schimmelpennink to Its Board. View article details on hiswai:

Excerpt

... biosimilar monoclonal antibodies. Before joining Alvotech, he worked for Pfizer Inc., Synthon BV, Hospira, Inc., and Numico NV in different positions.

Article found on: techstockobserver.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up